Manish Patel, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Houston, TXNPI 1942453071
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Abbott at 56.1% of the total. Reporting peaked in 2022 at $5,895 and has fallen 92.4% since, to $450 in 2025.
Across 104 payments — averaging $143.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$8K
- Transmedics, Inc.$2K
- Medtronic$1K
- Abiomed$1K
- Atricure, Inc.$399
- Baxter Healthcare$282
- plus $1K from 14 others
What the payments were for
- Consulting fees$5,53537%
- Travel & lodging$3,21522%
- Food & beverage$6,17341%
- Education$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 41 | $8,388 |
| Transmedics, Inc. | 1 | $2,081 |
| Medtronic(2 entities) | 15 | $1,473 |
| Abiomed | 13 | $1,140 |
| Atricure, Inc. | 5 | $399 |
| Baxter Healthcare | 2 | $282 |
| Helios Cardio Inc | 1 | $248 |
| Boston Scientific | 5 | $153 |
| Johnson & Johnson(2 entities) | 6 | $143 |
| Edwards Lifesciences | 1 | $136 |
| Chiesi USA, Inc. | 1 | $115 |
| Smith+Nephew | 5 | $82 |
| Wound Management Technologies, Inc | 1 | $78 |
| Livanova USA, Inc. | 1 | $66 |
| Optinose US, Inc. | 1 | $47 |
| Integra Lifesciences Corporation | 1 | $29 |
| Angiodynamics, Inc. | 1 | $24 |
| Cvrx, Inc. | 1 | $23 |
| Olympus America Inc. | 1 | $21 |
| GSK | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$5,123
- ORGAN CARE SYSTEM$2,081
- HeartWare HVAD$1,210
- CardioMEMS HF System$810
- Impella$558
- ATRICLIP LAA EXCLUSION SYSTEM$324
- Advisor Catheter$280
- CARDIAMEND$248
- FLOSEAL$245
- SYNERGY ABLATION SYSTEM$210
- AVEIR$167
- ADVISOR$156
- Agilis HisPro$153
- Quadra Assura CRT Defibrillator$149
- HeartMate 3 Left Ventricular Dev$141
- INSPIRIS RESILIA aortic valve$136
- Agilis NxT EP Introducer$134
- CARDIOMEMS$125
- HeartMate Touch$117
- CLEVIPREX$115
How this compares
$14,944 in reported general payments places this provider in the 70th percentile of 424 thoracic surgery (cardiothoracic vascular surgery) providers in Texas.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other thoracic surgery (cardiothoracic vascular surgery) in Houston
- Michael ReardonHouston$713K
- Danny RamzyHouston$527K
- Randall WolfHouston$283K
- Min KimHouston$185K
- Marc MoonHouston$142K
- Ismael Salas de ArmasHouston$121K
- Shawn GrothHouston$110K
- Mahesh RamchandaniHouston$110K
- Gabriel LoorHouston$106K
- Mara AntonoffHouston$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.